Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

[1]  P. Tricoci.  Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention. , 2017, Clinical chemistry.

[2]  C. Held,et al.  Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy , 2016, Circulation. Cardiovascular interventions.

[3]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.

[4]  Jonathan H Seltzer,et al.  Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium. , 2015, American heart journal.

[5]  C. Held,et al.  Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2014, Journal of the American College of Cardiology.

[6]  M. Mack,et al.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). , 2013, Journal of the American College of Cardiology.

[7]  R. Califf,et al.  Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. , 2013, Journal of the American College of Cardiology.

[8]  L. Newby,et al.  Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review. , 2013, European heart journal.

[9]  Deepak L. Bhatt,et al.  A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial , 2013, Heart.

[10]  R. Califf,et al.  Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. , 2012, Journal of the American College of Cardiology.

[11]  Marc P. Bonaca,et al.  Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial , 2012, The Lancet.

[12]  M. Pencina,et al.  Troponin criteria for myocardial infarction after percutaneous coronary intervention. , 2012, Archives of internal medicine.

[13]  Giuseppe Ambrosio,et al.  Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.

[14]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .

[15]  Dick M. Goedhart,et al.  The SYNTAX score revisited: A reassessment of the SYNTAX score reproducibility , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[16]  R. Califf,et al.  Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[17]  B. Gersh,et al.  Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2009, Journal of the American College of Cardiology.

[18]  M. Roea,et al.  Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes , 2004 .

[19]  Samin K. Sharma,et al.  Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. , 2004, The American journal of cardiology.

[20]  B. Nallamothu,et al.  Prognostic implication of troponin I elevation after percutaneous coronary intervention. , 2003, The American journal of cardiology.

[21]  V. Hasselblad,et al.  Prognostic significance of elevated troponin I after percutaneous coronary intervention. , 2002, Journal of the American College of Cardiology.

[22]  D. Baim,et al.  Reliability of the quantitative angiographic measurements in the New Approaches to Coronary Intervention (NACI) registry: a comparison of clinical site and repeated angiographic core laboratory readings. , 1997, The American journal of cardiology.